Exchange: NASDAQ·Updated 12:30 PM EDT
LNAI logo

LNAI Lunai Bioworks Inc.

$2.30
$0.049
(2.08%)
Today
EarningsSep 28
Mkt Cap$10.65M
Vol4,642.00

About LNAI

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
41

Bearish Sentiment

How do you feel about LNAI?

Advertisement|Remove ads.